Baroreceptor-aortic nerve-mediated release of endogenous L-3,4-dihydroxyphenylalanine and its tonic depressor function in the nucleus tractus solitarii of rats
- PMID: 7816196
- DOI: 10.1016/0306-4522(94)90321-2
Baroreceptor-aortic nerve-mediated release of endogenous L-3,4-dihydroxyphenylalanine and its tonic depressor function in the nucleus tractus solitarii of rats
Abstract
We have proposed that L-3,4-dihydroxyphenylalanine (L-DOPA) is a neurotransmitter and/or neuromodulator in the central nervous system [Misu Y. and Goshima Y. (1993) Trends pharmac. Sci. 14, 119-123]. This study aimed to explore whether or not endogenous L-DOPA, as a neurotransmitter candidate of the primary baroreceptor afferents, tonically functions to activate depressor neurons in the nucleus tractus solitarii of anesthetized rats. By parallel microdialysis in bilateral nucleus tractus solitarii areas, the basal L-DOPA release was in part inhibited by tetrodotoxin perfusion (1 microM) or Ca2+ deprivation, and was markedly reduced by alpha-methyl-p-tyrosine (200 mg/kg, i.p.), a tyrosine hydroxylase inhibitor. Forty to 100 mM K+ concentration-dependently released L-DOPA. Fifty millimoles K+ repetitively and constantly released L-DOPA. This release was Ca(2+)-dependent. Stimulation of the left aortic nerve (100 Hz, 8 V) repetitively and constantly released L-DOPA and this release was tetrodotoxin-sensitive. Phenylephrine i.v. infused produced L-DOPA release and reflex bradycardia, temporally associated with a rise and subsequent recovery of blood pressure. This release and bradycardia were abolished by denervation of the bilateral carotid sinus and aortic nerves. In addition, L-DOPA methyl ester, a competitive L-DOPA antagonist, when microinjected into depressor sites of the left nucleus tractus solitarii, antagonized depressor responses to mild stimulation (20 Hz, 3 V) of the ipsilateral aortic nerve. This antagonist alone, microinjected bilaterally, elicited a dose-dependent hypertension, which was abolished by alpha-methyl-p-tyrosine. Furthermore, by immunocytochemical analysis seven days after denervation of the left aortic nerve, tyrosine hydroxylase- and L-DOPA-, but not dopamine- and dopamine-beta-hydroxylase-immunoreactivities decreased in the ipsilateral nucleus tractus solitarii and dorsal motor vagus nucleus complex area. In the left ganglion nodosum, denervation decreased staining and number of L-DOPA-immunoreactive cells and staining of tyrosine hydroxylase-immunoreactive cells, but no modification of dopamine-immunoreactive cells was seen. Taken together with previous findings that L-DOPA itself is stereoselectively responsible for cardiovascular control in this nucleus, it is probable that L-DOPA is a neurotransmitter of the primary baroreceptor afferents terminating directly in depressor neurons and/or indirectly in some neurons within a microcircuit, including depressor neurons of the nucleus tractus solitarii. Endogenously released L-DOPA itself tonically functions to activate depressor neurons for regulation of blood pressure in the rat nucleus tractus solitarii.
Similar articles
-
L-dopaergic components in the caudal ventrolateral medulla in baroreflex neurotransmission.Neuroscience. 1999;92(1):137-49. doi: 10.1016/s0306-4522(98)00721-0. Neuroscience. 1999. PMID: 10392837
-
Altered tonic L-3,4-dihydroxyphenylalanine systems in the nucleus tractus solitarii and the rostral ventrolateral medulla of spontaneously hypertensive rats.Neuroscience. 1995 Jul;67(1):95-106. doi: 10.1016/0306-4522(94)00611-8. Neuroscience. 1995. PMID: 7477914
-
L-DOPA systems for blood pressure regulation in the lower brainstem.Neurosci Res. 1995 Sep;23(2):147-58. doi: 10.1016/0168-0102(95)00939-q. Neurosci Res. 1995. PMID: 8532212 Review.
-
An L-dopaergic relay from the posterior hypothalamic nucleus to the rostral ventrolateral medulla and its cardiovascular function in anesthetized rats.Neuroscience. 1999;92(1):123-35. doi: 10.1016/s0306-4522(98)00720-9. Neuroscience. 1999. PMID: 10392836
-
Neurobiology of L-DOPAergic systems.Prog Neurobiol. 1996 Aug;49(5):415-54. doi: 10.1016/0301-0082(96)00025-1. Prog Neurobiol. 1996. PMID: 8895995 Review.
Cited by
-
l-DOPA and Its Receptor GPR143: Implications for Pathogenesis and Therapy in Parkinson's Disease.Front Pharmacol. 2019 Oct 3;10:1119. doi: 10.3389/fphar.2019.01119. eCollection 2019. Front Pharmacol. 2019. PMID: 31632270 Free PMC article. Review.
-
The Many Faces of G Protein-Coupled Receptor 143, an Atypical Intracellular Receptor.Front Mol Biosci. 2022 Apr 12;9:873777. doi: 10.3389/fmolb.2022.873777. eCollection 2022. Front Mol Biosci. 2022. PMID: 35495622 Free PMC article. Review.
-
Effects of different levodopa doses on blood pressure in older patients with early and middle stages of Parkinson's disease.Heliyon. 2023 Jul 4;9(7):e17876. doi: 10.1016/j.heliyon.2023.e17876. eCollection 2023 Jul. Heliyon. 2023. PMID: 37483692 Free PMC article.
-
The protein Ocular albinism 1 is the orphan GPCR GPR143 and mediates depressor and bradycardic responses to DOPA in the nucleus tractus solitarii.Br J Pharmacol. 2014 Jan;171(2):403-14. doi: 10.1111/bph.12459. Br J Pharmacol. 2014. PMID: 24117106 Free PMC article.
-
L-DOPA sensitizes vasomotor tone by modulating the vascular alpha1-adrenergic receptor.JCI Insight. 2017 Sep 21;2(18):e90903. doi: 10.1172/jci.insight.90903. eCollection 2017 Sep 21. JCI Insight. 2017. PMID: 28931752 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous